Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) have received a consensus recommendation of “Hold” from the eleven research firms that are currently covering the firm, Marketbeat.com reports. Eight investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month target […]